Lungpacer Medical

lungpacer.com

LungPacer Medical, Inc., is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, and with U.S. offices in Exton, Pennsylvania, LungPacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients more safely and effectively. The LungPacer Diaphragm Pacing Therapy System™ is the first, minimally invasive, temporary transvenous diaphragmatic neurostimulation system that has FDA Emergency Use Authorization (EUA) for use during the COVID-19 pandemic. This non-surgical, non-implanted diaphragm stimulation therapy is delivered via a central venous catheter (LungPacer Intravenous Electrode - Live Catheter®), similar to catheters currently placed in mechanically ventilated ICU patients. The Live Catheter is intended to stimulate the diaphragm in conjunction with an invasive mechanical ventilator. This device is designed to strengthen a weakened diaphragm.